Policy Paper on Efficiency of WIDENING Measures

logo Alliance4Life

The recently published policy paper on the Efficiency of the Widening Measures, presented by Alliance4Life, provides valuable insights and recommendations based on the experiences of twelve progressive life science institutions and universities from Central and Eastern European (CEE) countries. The paper focuses on the widening measures Twinning, Teaming, and ERA Chairs,  examining their impact, challenges, and sustainability at both national and European levels.

The main objective of the document is to contribute to the strategic planning of Horizon Europe for the next period (2025-2027) and subsequent Horizon programmes. It builds upon Alliance4Life’s previous recommendations for Horizon Europe and aims to address the research and innovation (R&I) gap between Western and Eastern Europe.

The findings are based on interviews with representatives from Alliance4Life member institutions who have been involved in various widening actions. The interviews revealed several positive outcomes, including improved scientific cooperation, enhanced grant writing skills and administrative capacity, increased researcher mobility, and the ability to attract distinguished researchers from abroad. However, concerns were raised regarding the allocation of resources in widening projects, suggesting that a greater proportion of funding should be directed towards research activities rather than networking and administrative tasks.

The policy paper presents key recommendations for the EU, national governments, and research institutions. Firstly, it suggests shifting the EU widening paradigm from supporting to empowering, emphasising the need to enable widening institutions to become R&I leaders themselves. This entails establishing schemes that allow for actual research and innovation activities, fostering a sense of leadership among researchers from widening countries, and recognising existing Centres of Excellence (CoEs) in these countries.

Secondly, the paper highlights the importance of coordination between the EU and national governments in terms of the concertation of R&I capacities. It calls for strategic coordination in establishing new Centres of Excellence, ensuring sustainability, and involving existing CoEs in research policy development processes at the EU level.

Thirdly, the policy paper emphasises the need for better coordination of calls and the utilisation of synergies between different funding instruments. It suggests harmonising the application process and scheduling calls to reduce the administrative burden on widening institutions. The establishment of a Seal of Excellence Community of Practice is proposed to facilitate information sharing and best practices.

Lastly, the paper stresses the urgency of speeding up strategic changes at national, regional, and institutional levels. It calls for national R&I reforms, modern career paths for researchers, an international-friendly environment, targeted infrastructure investments, support for excellent research, promotion of existing CoEs, and addressing administrative capacity issues.

In conclusion, the policy paper on the Efficiency of the Widening Measures provides valuable insights and recommendations to improve the effectiveness and sustainability of widening actions in the field of life sciences. By empowering widening institutions, improving coordination between EU and national governments, enhancing synergies, and implementing strategic changes, the EU can bridge the R&I gaps and create a more efficient and competitive European Research Area.

Download the full version of the policy paper HERE


Alliance4Life Partners:
1. Masaryk University (CEITEC MU – Central European Institute of Technology), Czech
2. St. Anne’s University Hospital Brno (FNUSA-ICRC – International Clinical Research
Center), Czech Republic
3. Biomedical Research Center of the Slovak Academy of Sciences (BMC SAS), Slovakia
4. Medical University of Łodz (MUL), Poland
5. University of Zagreb School of Medicine (UZSM), Croatia
6. University of Tartu (TU), Estonia
7. Vilnius University – Faculty of Medicine (VU), Lithuania
8. Latvian Institute of Organic Synthesis (LIOS), Latvia
9. University of Ljubljana (UL), Slovenia
10. Semmelweis University (SU), Hungary
11. Medical University Sofia (MUS), Bulgaria
12. University of Medicine and Pharmacy (UMFCD), Romania


Source: Press Release Alliance4Life